Director, Pharma CDx Business Development, Northeast US (ADX-326-20)
COMPANY SUMMARY:
In October 2020, Invitae Corporation (NYSE: NVTA) combined with ArcherDX, a genomic analysis company specializing in cancer diagnostics and monitoring, to create a leading comprehensive medical and cancer genetics company. As a combined company, Invitae, is bringing world-class genetic testing and diagnostics into mainstream medicine to improve healthcare for billions of people. Our goal is to aggregate the world’s genetic tests into a single service with higher quality and accuracy, faster turnaround time and actionable results. Learn more at invitae.com and archerdx.com.
- Develop and execute business plans for targeted accounts. Complete a territory business analysis for management review on a quarterly basis.
- Maintain relationships with major Pharma customer to design and coordinate clinical trial strategy for early through later stage programs.
- Work with internal ArcherDX clinical market development and regulatory teams to deliver the product requirements within a regulated clinical trial environment.
- Identify Companion Diagnostic (CDx) opportunities and non-CDx opportunities (non-registrational, research, etc)
- Implement pipeline strategy for ArcherDX products/applications to support Clinical Trials (ie. Solid tumor, heme oncology, immune-oncology, CART/gene therapy, etc)
- Maintain and develop the CRM database, provide monthly sales pipelines and forecasts
- Review, understanding, and compliance with all Regulatory and required policies and procedures (ie. GDPR, IT, etc).
- Minimum 5 years of business development, sales or market development experience with direct ownership of Key Accounts (Pharma/CRO preferred)
- Skilled communicator comfortable working with personalized medicine and effective communicating to both internal and external audiences; a team player
- Strong understanding of NGS as well as Pharmaceutical therapeutic development in personalized and targeted medicine
- Self-starter with the ability to create and execute plans
- Ability to build and analyze models to forecast and track results
- Understanding of Regulatory Requirements (GLP, GCP, GMP, CLIA) within a Drug Development process including Phase I, II, III, IV clinical trials associated with personalized medicine requirements.
- Willingness to travel (50-75%) and residence in the Northeast United States
- Assigned Key Accounts and other accounts in US and/or global where Candidate has strong relationships. Candidates should live on the east or west coast, and be familiar with the area and accounts
- Graduate (minimum) qualification in an appropriate science subject, molecular biology preferred